Gastroenterology · Peptic Ulcer Disease
The facts most likely to be tested
Helicobacter pylori is the most common cause of duodenal ulcers and is strongly associated with gastric adenocarcinoma and MALT lymphoma.
The urea breath test and stool antigen test are the preferred non-invasive diagnostic modalities for active infection.
Patients must discontinue proton pump inhibitors (PPIs) for two weeks and bismuth/antibiotics for four weeks prior to testing to avoid false-negative results.
Endoscopic biopsy with rapid urease testing is the gold standard for diagnosis in patients requiring an EGD for alarm symptoms.
First-line treatment is quadruple therapy consisting of a PPI, bismuth subsalicylate, metronidazole, and tetracycline for 14 days.
Clarithromycin-based triple therapy is no longer recommended as a first-line treatment due to high rates of antibiotic resistance.
Confirmation of eradication via repeat urea breath test or stool antigen test is required at least four weeks after completing therapy.
Vignette unlocked
A 45-year-old male presents with a three-month history of epigastric pain that improves with meals but worsens 2-3 hours later. He reports occasional melena and has lost 5 pounds due to fear of eating. He has been taking omeprazole daily for the past month to manage his symptoms. Physical examination reveals mild epigastric tenderness without guarding or rebound. An endoscopy is performed, revealing a 1 cm duodenal ulcer.
Which diagnostic test is most appropriate to confirm the presence of H. pylori in this patient?
Rapid urease test (CLO test) via endoscopic biopsy
Because the patient is already undergoing endoscopy for alarm symptoms (weight loss, melena), a biopsy-based rapid urease test is the most efficient diagnostic method, as non-invasive tests would be unreliable due to his current PPI use.
Full handout
High yield triage
Etiology / Epidemiology
Gram-negative, spiral-shaped rod transmitted via fecal-oral or oral-oral routes. Primary risk factor is low socioeconomic status and crowded living conditions.
Clinical Manifestations
Often asymptomatic; presents as dyspepsia, epigastric pain, or peptic ulcer disease. Hematemesis or melena suggests active ulceration.
Diagnosis
Urea breath test or stool antigen test are the non-invasive gold standards. Must hold PPIs for 2 weeks prior to testing.
Treatment
First-line is quadruple therapy: Bismuth subsalicylate, Metronidazole, Tetracycline, and a PPI for 14 days.
Prognosis
Strong association with gastric adenocarcinoma and MALT lymphoma. Eradication reduces risk of recurrent ulcers.
Full handout
Epidemiology & Etiology
Infection is highly prevalent globally, often acquired in childhood. Transmission is facilitated by poor sanitation and close contact. It is the leading cause of chronic gastritis worldwide.
Pertinent Anatomy
Colonizes the gastric antrum primarily, where it thrives in the acidic environment. It utilizes urease to create a protective alkaline microenvironment, allowing survival beneath the gastric mucus layer.
Pathophysiology
The organism produces urease, which converts urea to ammonia, neutralizing gastric acid. This leads to mucosal inflammation, epithelial cell damage, and increased gastrin release. Chronic inflammation results in atrophic gastritis and loss of somatostatin-producing D-cells.
Clinical Manifestations
Patients typically report gnawing epigastric pain that may improve or worsen with food. Red flag symptoms include unintentional weight loss, dysphagia, and iron deficiency anemia. Chronic infection is the primary driver of peptic ulcer disease.
Diagnosis
The urea breath test is the most accurate non-invasive test for active infection. Endoscopy with biopsy is reserved for patients with alarm symptoms or those >60 years old. False negatives occur if the patient has taken PPIs or antibiotics within 2-4 weeks of testing.
Treatment
Standard quadruple therapy is required due to rising resistance. Metronidazole must be avoided if the patient has consumed alcohol due to the disulfiram-like reaction. Tetracycline is teratogenic and contraindicated in children and pregnancy.
Prognosis
Successful eradication is confirmed via urea breath test or stool antigen 4 weeks post-treatment. Failure to treat increases the risk of gastric adenocarcinoma and MALT lymphoma. Long-term monitoring is required for patients with pre-malignant changes.
Differential Diagnosis
NSAID-induced gastritis: history of chronic analgesic use
Zollinger-Ellison syndrome: refractory ulcers with high gastrin levels
Gastric cancer: weight loss and early satiety
GERD: retrosternal burning rather than epigastric pain
Functional dyspepsia: diagnosis of exclusion with normal endoscopy